CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
Dong-Ryeol Ryu
Kidney Res Clin Pract. 2017;36(3):207-208.   Published online September 30, 2017
DOI: https://doi.org/10.23876/j.krcp.2017.36.3.207

Excel Download

The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
Dong-Ryeol Ryu
Kidney Research and Clinical Practice. 2017;36(3):207-208   Crossref logo
Link1 Link2
Integrated in silico – in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat
Dina S. Ghallab, Eman Shawky, Ali M. Metwally, Ismail Celik, Reham S. Ibrahim, Mohamed M. Mohyeldin
RSC Advances. 2022;12(5):2843-2872   Crossref logo
Link1
Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users
Chengsheng Ju, Rachel Wing Chuen Lai, Ka Hou Christien Li, Joshua Kai Fung Hung, Jenny C L Lai, Jeffery Ho, Yingzhi Liu, Man Fung Tsoi, Tong Liu, Bernard Man Yung Cheung, Ian Chi Kei Wong, Lai Shan Tam, Gary Tse
Rheumatology. 2019;59(9):2340-2349   Crossref logo
Link1 Link2
Xanthine oxidase inhibition in SARS-CoV-2 infection: the mechanism and potency of allopurinol and febuxostat in COVID-19 management
Irandi Putra Pratomo, Anna Ariane, Aryo Tedjo, Rudi Heryanto, Rafika Indah Paramita
Medical Journal of Indonesia. 2020;30(1):   Crossref logo
Link1 Link2 Link3 Link4
Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity
Andrija Šmelcerović, Katarina Tomović, Žaklina Šmelcerović, Živomir Petronijević, Gordana Kocić, Tihomir Tomašič, Žiga Jakopin, Marko Anderluh
European Journal of Medicinal Chemistry. 2017;135:491-516   Crossref logo
Link1 Link2
Allopurinol/febuxostat
Reactions Weekly. 2023;1945(1):35-35   Crossref logo
Link1 Link2 Link3
2-Benzamido-4-methylthiazole-5-carboxylic Acid Derivatives as Potential Xanthine Oxidase Inhibitors and Free Radical Scavengers
Md. Rahmat Ali, Suresh Kumar, Obaid Afzal, Nishtha Shalmali, Wazid Ali, Manju Sharma, Sandhya Bawa
Archiv der Pharmazie. 2017;350(2):1600313   Crossref logo
Link1 Link2
Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
Andreas Jordan, Ursula Gresser
Pharmaceuticals. 2018;11(2):51   Crossref logo
Link1
Febuxostat: new xanthine oxidase inhibitor for gout
Steve Chaplin, Michael Doherty
Prescriber. 2011;22(3):14-20   Crossref logo
Link1 Link2 Link3
The Role of Urate and Xanthine Oxidase Inhibitors in Cardiovascular Disease
Jacob George, Allan D. Struthers
Cardiovascular Drug Reviews. 2008;26(1):59-64   Crossref logo
Link1 Link2